SUBSTANCE-RELATED DISORDERS
Clinical trials for SUBSTANCE-RELATED DISORDERS explained in plain language.
Never miss a new study
Get alerted when new SUBSTANCE-RELATED DISORDERS trials appear
Sign up with your email to follow new studies for SUBSTANCE-RELATED DISORDERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Magic mushroom compound tested for meth addiction – but trial stopped early
Symptom relief TerminatedThis study tested whether psilocybin, the active ingredient in magic mushrooms, is safe and feasible for people with methamphetamine use disorder. Only 5 participants were enrolled, and the trial was terminated early, so the results are very limited. The goal was to see if psiloc…
Matched conditions: SUBSTANCE-RELATED DISORDERS
Phase: PHASE1 • Sponsor: University of Wisconsin, Madison • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC
-
App aims to boost substance use treatment in Doctor's offices
Knowledge-focused TerminatedThis study tested whether a mobile app (eIntervention) could help adults with moderate to high-risk drug or alcohol use reduce their substance use and get into treatment. Participants were primary care patients who screened positive for substance use. The app was added to standar…
Matched conditions: SUBSTANCE-RELATED DISORDERS
Phase: NA • Sponsor: Chess Mobile Health • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:08 UTC